Print Page  |  Close Window

SEC Filings

8-K
TERRAFORM GLOBAL, INC. filed this Form 8-K on 11/14/2017
Entire Document
 
 
Reg. G: Reconciliation of Net Operating Revenue to Adjusted Revenue, Net Income / (Loss) to Adjusted EBITDA and Adjusted EBITDA to CAFD $000s, unless otherwise noted 10 Three Months Ended, September 2017 Three Months Ended, September 2016 Operating revenue, net 67,427 55,055 Amortization of favorable and unfavorable rate revenue contracts, net (a) 327 220 Adjusted revenue 67,754 55,275 Adjustments to reconcile net income to adjusted EBITDA and cash available for distribution Three Months Ended, September 2017 Three Months Ended, September 2016 Net income (36,711) (17,855) Add/(Subtract): Interest expense, net 29,121 33,159 Income tax expense (benefit) 2,490 2,121 Depreciation , accretion and amortization expense 16,562 13,594 General and administrative expense - G&A (b) 9,057 9,994 Non-cash stock-based compensation 750 646 Acquisition, formation and related cost (c) 15 139 Costs associated with shareholder litigation (d) 33,000 - Loss (gain) on foreign currency exchange, net (e) (7,114) 4,268 Loss (gain) on extinguishment of debt, net (36) 5 Other net loss (income) 14 (6,762) Other non-operating expenses (f) 274 - Adjusted EBITDA 47,421 39,308 Add/(Subtract): Interest payment (52,487) (49,921) Scheduled project level and other debt service and repayments (1,942) (2,790) Cash distributions to non-controlling interests - - Non-expansionary capital expenditures (423) (2,835) Change in restricted cash (g) 5,284 4,258 BioTherm dividend receipt (h) 2,887 1,731 Settlement gain/(loss) on foreign currency exchange related to operations (5,181) (2,914) Other (including interest income received) (i) 1,098 439 Cash available for distribution (3,343) (12,724) Exhibit 99.1